3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
3
Thoracic
2
Gastrointestinal
2
Other solid neoplasm
1
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
19
Ovarian Neoplasms
12
Fallopian Tube Neoplasms
9
Stomach Neoplasms
4
Vulvar Neoplasms
3
Vaginal Neoplasms
2
Peritoneal Neoplasms
2
Mesothelioma, Malignant
2
Carcinoma, Ovarian Epithelial
2
Brenner Tumor
2
Vomiting
1
Uterine Neoplasms
1
Triple Negative Breast Neoplasms
1
Sertoli-Leydig Cell Tumor
1
Sarcoma
1
Rhabdomyosarcoma
1
Recurrent Uterine Corpus Carcinoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Penile Neoplasms
1
Pelvic Neoplasms
1
Ovarian gynandroblastoma
1
Neoplasm Metastasis
1
Nausea
1
Lung Neoplasms
1
Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified
1
Locally Advanced Cervical Carcinoma
1
Locally Advanced Cervical Adenocarcinoma
1
Liposarcoma
1
HIV Infections
1
Interventions
Filgrastim
15
Carboplatin
10
Ifosfamide
9
Doxorubicin
9
Cyclophosphamide
9
Peripheral Blood Stem Cell Transplantation
7
pembrolizumab
6
Radiotherapy
6
Gemcitabine
6
Temozolomide
5
Etoposide
5
Cisplatin
5
Paclitaxel
4
Docetaxel
4
Amifostine
4
aldesleukin
3
aflibercept
3
Trastuzumab
3
Specimen Handling
3
Radiosurgery
3
Psychiatric Rehabilitation
3
Magnetic Resonance Spectroscopy
3
Biopsy
3
tislelizumab
2
sodium thiosulfate
2
selinexor
2
pazopanib
2
palbociclib
2
etoposide phosphate
2
eribulin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma
×
Platinum
×
Gynecologic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled